{"id":"556830-4652","orgnr":"556830-4652","name":"Uppsala Pharma AB","name_registered_on":"2014-08-21","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2010-12-08","business_description":"Bolagets huvudinriktning skall vara att bedriva medicinsk forskning och utveckling samt försäljning av medicinska preparat.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"},{"code":"90110","name":"Litterärt skapande och musikkomposition"}],"postal_address":{"street":"Södra Rudbecksgatan 4","care_of":"c/o Tom Saldeen","postal_code":"75236","city":"UPPSALA","country":"SE","municipality":{"code":"0380","name":"Uppsala"},"county":{"code":"03","name":"Uppsala län"}},"registered_office":{"municipality":{"code":"0380","name":"Uppsala"},"county":{"code":"03","name":"Uppsala län"}},"activity_status":"active","employee_class":{"code":"1","name":"0 anställda"},"turnover_class":{"code":"0","name":"< 1 tkr","year":2025},"f_tax":"never_registered","vat":"registered","employer":"never_registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-03-26","documents":{"annual_report":"/v1/documents/558752cd-9132-4970-bbe2-4988056cbfa7.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/14_2.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-06-03","documents":{"annual_report":"/v1/documents/6b295cb1-82a8-4540-8fa7-26c71f2b16a8.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/24_4.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-04-23","documents":{"annual_report":"/v1/documents/0da31f7d-56a0-4dae-8445-eddfb3164830.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/17_2.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-02-28","documents":{"annual_report":"/v1/documents/5a4cb301-42a9-4f04-bb8e-cb91f2b13620.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/09_2.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-02-24","documents":{"annual_report":"/v1/documents/dc6dfe4d-15d5-40a1-be5b-6a6d9a49a0ea.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/08_1.zip"}},{"from":"2020-01-01","to":"2020-12-31","framework":"K2","signed_on":"2021-04-22","documents":{"annual_report":"/v1/documents/55bc78ea-689e-4d58-b6ee-9bdfd98687d6.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/16_1.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":0,"operating_profit":-7312,"profit_after_financial_items":75168,"net_profit":59772,"total_assets":4064274,"current_assets":4058187,"equity":3412849,"share_capital":50000,"unrestricted_equity":3362849,"long_term_liabilities":608500,"current_liabilities":42925,"tax_liabilities":42925,"cash":3999166,"equity_ratio":0.8397,"source":{"annual_report":"2025-12-31","document":"/v1/documents/558752cd-9132-4970-bbe2-4988056cbfa7.xhtml"},"anchors":{"cash":{"text":"3 999 166","prefix":"Summa kassa och bank","suffix":"3 925 703"},"current_assets":{"text":"4 058 187"},"current_liabilities":{"text":"42 925","prefix":"skulder"},"equity":{"text":"3 412 849","prefix":"kapital"},"equity_ratio":{"text":"83,97"},"long_term_liabilities":{"text":"608 500","prefix":"långfristiga skulder"},"net_profit":{"text":"59 772","suffix":"107"},"net_sales":{"text":"0"},"profit_after_financial_items":{"text":"75 168"},"share_capital":{"text":"50 000","prefix":"utgång"},"tax_liabilities":{"text":"42 925","prefix":"Skatteskulder"},"total_assets":{"text":"4 064 274","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"3 362 849","prefix":"772"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-03-26","signatories":[{"name":"B*****","role":"Styrelsesuppleant"}]}}